More recent studies reported higher prevalence of DCIS incidentally diagnosed during risk reducing mastectomy in BRCA1 and BRCA2 PSV carriers—Kauff and coworkers compared BRCA carriers with age- and race-matched controls without a known cancer predisposition. This evidence concerns the gene BRCA2 and cancer.